Physician profile
Paul A Meyer
NPI 1235139619
$1,264.48
in general payments reported to CMS, 2019-2025
21 companies · $51.01 in 2025
The $51.01 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $67.91 · 2021: $23.02 · 2022: $200 · 2024: $27.41 · 2025: $51.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $167.07 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $147.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.29 | 2019 | |
| Pfizer INC. | $115.06 | 2019-2025 | |
| Abbvie INC. | $83.05 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $69.95 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $69.46 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.33 | 2019-2022 | |
| Novo Nordisk INC | $65.37 | 2019 | |
| Glaxosmithkline, LLC. | $55.36 | 2019 | |
| Amarin Pharma, INC. | $50.41 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $44.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $27.41 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.19 | 2022 | |
| Nestle Healthcare Nutrition INC. | $25.95 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.91 | 2019 | |
| Horizon Therapeutics Plc | $24.77 | 2019 | |
| Boston Scientific Corporation | $22.52 | 2025 | Watchman Flx |
| Philips North America LLC | $18.13 | 2019 | |
| Corcept Therapeutics | $15.64 | 2019 | |
| Amgen INC. | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.